Back
Anebulo Pharmaceuticals 10K Form
Sell
38
ANEB
Anebulo Pharmaceuticals
Last Price:
1.42
Seasonality Move:
11.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ANEB News And Ratings
See the #1 stock for the next 7 days that we like better than ANEB
ANEB Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.69M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.07 |
| Price / Book: | 20.49 |
Profitability
| EPS (TTM): | -0.30000 |
|---|---|
| Net Income (TTM): | $-7.92M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Anebulo Pharmaceuticals Earnings Forecast
Key Anebulo Pharmaceuticals Financial Ratios
- The Interest Expense is -1.84% of Operating Income.
- Per Share Earnings over the last 4 years have been positive in 2 years.
Anebulo Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ANEB |
| Website: | anebulo.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ANEB Technical Analysis vs Fundamental Analysis
Sell
38
Anebulo Pharmaceuticals (ANEB)
is a Sell
Is Anebulo Pharmaceuticals a Buy or a Sell?
-
Anebulo Pharmaceuticals stock is rated a Sell
The current Anebulo Pharmaceuticals [ANEB] share price is $1.50. The Score for ANEB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.